Analyst Research: Repligen Corp (RGEN.OQ)
RGEN.OQ on NASDAQ Stock Exchange Global Select Market
10.23USD
1 Aug 2013
10.23USD
1 Aug 2013
Price Change (% chg)
$0.06 (+0.59%)
$0.06 (+0.59%)
Prev Close
$10.17
$10.17
Open
$10.46
$10.46
Day's High
$10.68
$10.68
Day's Low
$10.11
$10.11
Volume
101,040
101,040
Avg. Vol
84,065
84,065
52-wk High
$10.68
$10.68
52-wk Low
$3.90
$3.90
| Name | Age | Since | Current Position |
|---|---|---|---|
Karen Dawes |
60 | 2011 | Independent Chairman of the Board |
Alexander Rich |
87 | 2011 | Independent Chairperson Emeritus of the Board |
Walter Herlihy |
60 | 1996 | President, Chief Executive Officer, Director |
Jonathan Lieber |
40 | 2012 | Chief Financial Officer, Treasurer, Principal Financial Officer |
Michael Hall |
50 | 2011 | Chief Medical Officer and Senior Vice President - Clinical and Regulatory Affairs |

